Eksigent serves the life science, drug discovery and pharmaceutical industries, expanding customer possibilities with low-flow fluid delivery solutions. From precise separation of precious samples in proteomics research to fast and efficient analytical chromatography to unique medical devices that improve the way drugs are delivered, Eksigent brings novel solutions to customer challenges. The company combines proprietary microfluidic pumping technology with creative approaches that help customers improve productivity and expand their research and market opportunities. Eksigent serves customers throughout the world, including Europe, Asia and Australia, through a growing sales and service network. For more information, visit www.eksigent.com.
Amgen; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Merck; Pfizer; European Molecular Biology Lab; Lilly; Mayo Clinic; McMaster University; National Institutes of Health; Sandia National Laboratories; The Scripps Research Institute; The Wistar Institute; University of California, San Francisco